TerrAscend (TSNDF) Shares Outstanding (2020 - 2026)
TerrAscend (TSNDF) posted quarterly Shares Outstanding (Entity) of $308.5 million for Q1 2026, up 5.26% year-over-year from $293.1 million in Q1 2025, and up 2.47% quarter-over-quarter from $301.1 million in Q4 2025.
TerrAscend (TSNDF) Shares Outstanding (2020 - 2026) Analysis & Trends
TerrAscend (TSNDF) has reported Shares Outstanding (Entity) for 7 consecutive years, with $308.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 5.26% year-over-year to $308.5 million; the TTM figure through Mar 2026 stood at $308.5 million (up 5.26% YoY), while the FY2025 annual figure was $301.1 million, up 3.28% from the prior year.
- Shares Outstanding (Entity) improved to $308.5 million in Q1 2026 per TSNDF's latest filing, from $301.1 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $254.4 billion in Q3 2022 and bottomed at $211.1 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $30.1 billion across 5 years, with a median of $291.5 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 38.35% — and 2023, when it tumbled 99.89%.
- TerrAscend's Shares Outstanding (Entity) stood at $244.4 million in 2022, then grew by 14.3% to $279.3 million in 2023, then climbed by 4.38% to $291.5 million in 2024, then gained by 3.28% to $301.1 million in 2025, then gained by 2.47% to $308.5 million in 2026.
- Business Quant data shows TSNDF's Shares Outstanding (Entity) at $308.5 million in Q1 2026, $301.1 million in Q4 2025, and $306.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 4.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 417.60 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 42.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 101.00 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 499.50 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 832.44 Mn |
| 10 | TerrAscend | 187.17 Mn | 145.05 Mn | 36.25 Mn | 309.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 309.36 Mn |
| Mar 31, 2026 | 308.53 Mn |
| Dec 31, 2025 | 301.08 Mn |
| Sep 30, 2025 | 306.30 Mn |
| Jun 30, 2025 | 299.09 Mn |
| Mar 31, 2025 | 293.12 Mn |
| Dec 31, 2024 | 291.51 Mn |
| Sep 30, 2024 | 291.65 Mn |
| Jun 30, 2024 | 291.49 Mn |
| Mar 31, 2024 | 290.62 Mn |
| Dec 31, 2023 | 279.29 Mn |
| Sep 30, 2023 | 287.07 Mn |
| Jun 30, 2023 | 275.19 Mn |
| Mar 31, 2023 | 267.21 Mn |
| Dec 31, 2022 | 244.35 Mn |
| Sep 30, 2022 | 254.36 Bn |
| Jun 30, 2022 | 252.31 Bn |
| Mar 31, 2022 | 211.13 Mn |
| Dec 31, 2021 | 181.06 Mn |
| Sep 30, 2021 | 184.44 Bn |